Roel, E., Pistillo, A., Recalde, M., Sena, A., Fernández-Bertolín, S., Aragón, M., Puente, D., Ahmed, W., Alghoul, H., Alser, O., Alshammari, T., Areia, C., Blacketer, C., Carter, W., Casajust, P., Culhane, A., Dawoud, D., DeFalco, F., DuVall, S., Falconer, T., Golozar, A., Gong, M., Hester, L., Hripcsak, G., Tan, E., Jeon, H., Jonnagaddala, J., Lai, L., Lynch, K., Matheny, M., Morales, D., Natarajan, K., Nyberg, F., Ostropolets, A., Posada, J., Prats-Uribe, A., Reich, C., Rivera, D., Schilling, L., Soerjomataram, I., Shah, K., Shah, N., Shen, Y., Spotnitz, M., Subbian, V., Suchard, M., Trama, A., Zhang, L., Zhang, Y., Ryan, P., Prieto-Alhambra, D., Kostka, K. & Duarte-Salles, T. 2021, 'Characteristics and outcomes of over 300,000 COVID-19 individuals with history of cancer in the United States and Spain', Cancer Epidemiology, Biomarkers and Prevention. https://doi.org/10.1158/1055-9965.EPI-21-0266